​

Twist Bioscience (TWST) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Twist Bioscience Revenue Highlights

Latest Revenue (Y)

$312.97M

Latest Revenue (Q)

$81.46M

Main Segment (Y)

Ngs Tools

Main Geography (Y)

Americas

Twist Bioscience Revenue by Period

Twist Bioscience Revenue by Year

DateRevenueChange
2024-09-30$312.97M27.69%
2023-09-30$245.11M20.41%
2022-09-30$203.56M53.83%
2021-09-30$132.33M46.87%
2020-09-30$90.10M65.67%
2019-09-30$54.38M113.89%
2018-09-30$25.43M136.16%
2017-09-30$10.77M374.53%
2016-09-30$2.27M-

Twist Bioscience generated $312.97M in revenue during NA 2024, up 27.69% compared to the previous quarter, and up 575.48% compared to the same period a year ago.

Twist Bioscience Revenue by Quarter

DateRevenueChange
2024-06-30$81.46M8.18%
2024-03-31$75.30M5.32%
2023-12-31$71.50M6.80%
2023-09-30$66.95M5.03%
2023-06-30$63.74M5.92%
2023-03-31$60.18M10.95%
2022-12-31$54.24M-5.34%
2022-09-30$57.31M2.13%
2022-06-30$56.11M16.59%
2022-03-31$48.13M14.54%
2021-12-31$42.02M10.72%
2021-09-30$37.95M8.38%
2021-06-30$35.02M12.22%
2021-03-31$31.20M10.81%
2020-12-31$28.16M-13.17%
2020-09-30$32.43M52.93%
2020-06-30$21.21M9.90%
2020-03-31$19.30M12.43%
2019-12-31$17.16M9.07%
2019-09-30$15.74M15.71%
2019-06-30$13.60M0.32%
2019-03-31$13.56M17.97%
2018-12-31$11.49M36.70%
2018-09-30$8.41M28.53%
2018-06-30$6.54M6.08%
2018-03-31$6.17M42.96%
2017-12-31$4.31M24.44%
2017-09-30$3.47M-

Twist Bioscience generated $81.46M in revenue during Q3 2024, up 8.18% compared to the previous quarter, and up 135.37% compared to the same period a year ago.

Twist Bioscience Revenue Breakdown

Twist Bioscience Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceSep 24Sep 23Sep 22Sep 21Sep 20
Oligo Pools$16.91M$14.49M$12.42M$8.04M$4.54M
Synthetic Genes$92.68M$73.54M$61.51M$38.96M$35.19M
Antibody Discovery$20.33M$23.17M$24.17M--
Dna And Biopharma Libraries$13.93M$10.20M$6.15M$12.66M-
Ngs Tools$169.13M$123.71M$99.31M$72.67M-
NGS Tools----$44.02M
DNA And Biopharma Libraries----$6.35M

Twist Bioscience's latest annual revenue breakdown by segment (product or service), as of Sep 24: Ngs Tools (54.04%), Synthetic Genes (29.61%), Antibody Discovery (6.50%), Oligo Pools (5.40%), and Dna And Biopharma Libraries (4.45%).

Quarterly Revenue by Product

Product/ServiceSep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19
Oligo Pools$4.61M$4.17M$3.94M$4.19M$3.74M$3.73M$3.31M$3.70M$3.67M$3.26M$2.31M$3.19M$2.67M$2.02M$1.84M$1.51M$1.20M$1.00M$1.10M$1.24M
Antibody Discovery$5.30M$5.10M$4.70M$5.23M$3.39M$4.58M$7.03M$8.17M$6.53M$6.24M$6.59M$4.81M--------
Synthetic Genes$25.65M$24.95M$22.36M$19.73M$20.05M$19.30M$18.01M$16.18M$16.42M$17.40M$14.16M$13.53M$9.74M$11.16M$9.19M$8.87M$8.64M$9.60M$9.12M$7.84M
Dna And Biopharma Libraries$3.62M$3.85M$3.53M$2.94M$2.66M$2.88M$2.83M$1.84M$1.50M$1.42M$1.97M$1.26M$4.10M$3.14M$3.22M-----
Ngs Tools$45.54M$43.40M$40.77M$39.42M$37.11M$33.24M$28.99M$24.36M$29.19M$27.79M$23.10M$19.23M$21.45M$18.70M$16.95M-----
NGS Tools---------------$15.57M$20.18M$9.08M$7.73M$7.03M
DNA And Biopharma Libraries---------------$2.21M$2.42M$1.52M$1.35M-
DNA Libraries-------------------$1.06M

Twist Bioscience's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Ngs Tools (53.76%), Synthetic Genes (30.28%), Antibody Discovery (6.26%), Oligo Pools (5.44%), and Dna And Biopharma Libraries (4.27%).

Twist Bioscience Revenue Breakdown by Country

Annual Revenue by Country

CountrySep 24Sep 23Sep 22Sep 21Sep 20
Asia Pacific$26.52M$22.46M$19.01M$10.30M$5.12M
EMEA$92.57M$71.39M$62.08M$25.82M-
Americas$193.88M$151.26M$122.47M$77.91M$1.08M
E M E A---$44.12M-
UNITED STATES----$58.08M

Twist Bioscience's latest annual revenue breakdown by geography, as of Sep 24: Americas (61.95%), EMEA (29.58%), and Asia Pacific (8.47%).

Quarterly Revenue by Country

CountrySep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19
Americas$52.66M$51.39M$45.87M$43.96M$43.68M$39.02M$34.92M$33.65M$34.84M$35.80M$28.46M$22.61M$76.58M$544.00K$484.00K$302.00K$290.00K$269.00K$369.00K-
EMEA$25.50M$23.58M$22.26M$21.22M$17.21M$19.07M$18.78M$16.33M$16.87M$15.48M$15.20M$9.06M$7.25M$6.39M$6.23M$5.94M----
Asia Pacific$6.54M$6.49M$7.17M$6.32M$6.06M$5.66M$6.47M$4.27M$5.60M$4.83M$4.46M$4.04M$2.77M$3.10M$2.67M$1.77M$1.75M$1.18M$944.00K$1.24M
E M E A-----------$15.37M$12.43M$12.66M$9.98M-----
U-------------$18.72M$18.08M-----
UNITED STATES---------------$17.03M$23.14M$13.37M$11.75M$9.83M
North America-------------------$155.00K

Twist Bioscience's latest quarterly revenue breakdown by geography, as of Sep 24: Americas (62.17%), EMEA (30.11%), and Asia Pacific (7.73%).

Twist Bioscience Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
TMOThermo Fisher Scientific$42.86B$10.60B
IQVIQVIA$14.98B$3.90B
DHRDanaher$14.03B$3.40B
ICLRICON Public Limited Company$8.12B$2.09B
AAgilent$6.83B$1.58B
ILMNIllumina$4.50B$1.08B
MTDMettler-Toledo$3.79B$954.53M
WATWaters$2.96B$740.30M
EXASExact Sciences$2.50B$708.65M
NTRANatera$1.08B$439.76M
GHGuardant Health$563.95M$177.24M
TWSTTwist Bioscience$312.97M$81.46M
CDNACareDx$280.32M$82.88M
CSTLCastle Biosciences$219.79M$85.78M
PSNLPersonalis$73.48M$22.58M

TWST Revenue FAQ

What is Twist Bioscience’s yearly revenue?

Twist Bioscience's yearly revenue for 2024 was $312.97M, representing an increase of 27.69% compared to 2023. The company's yearly revenue for 2023 was $245.11M, representing an increase of 20.41% compared to 2022. TWST's yearly revenue for 2022 was $203.56M, representing an increase of 53.83% compared to 2021.

What is Twist Bioscience’s quarterly revenue?

Twist Bioscience's quarterly revenue for Q3 2024 was $81.46M, a 8.18% increase from the previous quarter (Q2 2024), and a 27.81% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $75.3M, a 5.32% increase from the previous quarter (Q1 2024), and a 25.13% increase year-over-year (Q2 2023). TWST's quarterly revenue for Q1 2024 was $71.5M, a 6.80% increase from the previous quarter (Q4 2023), and a 31.81% increase year-over-year (Q1 2023).

What is Twist Bioscience’s revenue growth rate?

Twist Bioscience's revenue growth rate for the last 3 years (2022-2024) was 53.75%, and for the last 5 years (2020-2024) was 247.36%.

What are Twist Bioscience’s revenue streams?

Twist Bioscience's revenue streams in p 24 are Oligo Pools, Synthetic Genes, Antibody Discovery, Dna And Biopharma Libraries, and Ngs Tools. Oligo Pools generated $16.91M in revenue, accounting 5.40% of the company's total revenue, up 16.68% year-over-year. Synthetic Genes generated $92.68M in revenue, accounting 29.61% of the company's total revenue, up 26.02% year-over-year. Antibody Discovery generated $20.33M in revenue, accounting 6.50% of the company's total revenue, down -12.27% year-over-year. Dna And Biopharma Libraries generated $13.93M in revenue, accounting 4.45% of the company's total revenue, up 36.58% year-over-year. Ngs Tools generated $169.13M in revenue, accounting 54.04% of the company's total revenue, up 36.72% year-over-year.

What is Twist Bioscience’s main source of revenue?

For the fiscal year ending Sep 24, the largest source of revenue of Twist Bioscience was Ngs Tools. This segment made a revenue of $169.13M, representing 54.04% of the company's total revenue.